» Articles » PMID: 21084301

HES1 (hairy and Enhancer of Split 1) is a Determinant of Bone Mass

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2010 Nov 19
PMID 21084301
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

HES1 (hairy and enhancer of split) is a transcription factor that regulates osteoblastogenesis in vitro. The skeletal effects of HES1 misexpression were studied. Transgenic mice where a 3.6-kilobase fragment of the collagen type 1 α1 promoter directs HES1 overexpression were created. Transgenics were osteopenic due to decreased osteoblast function in female and increased bone resorption in male mice. HES1 impaired osteoblastogenesis in vitro, and transgenic osteoblasts enhanced the resorptive activity of co-cultured osteoclast precursors. Mice homozygous for a Hes1 loxP-targeted allele were bred to transgenics, where the paired-related homeobox gene enhancer or the osteocalcin promoter direct Cre recombinase expression to inactivate Hes1 in the limb bud or in osteoblasts. To avoid genetic compensation, Hes1 was inactivated in the context of the global deletion of Hes3 and Hes5. Hes3 and Hes5 null mice had no skeletal phenotype. Hes1 inactivation in the limb bud increased femoral length and trabecular number. Hes1 inactivation in osteoblasts increased trabecular bone volume, number, and connectivity due to increased mineral apposition rate and suppressed bone resorption. Hes1 inactivation in vitro increased alkaline phosphatase expression and suppressed the resorptive activity of co-cultured osteoclast precursors. In conclusion, by inhibiting osteoblast function and inducing bone resorption, HES1 is an intracellular determinant of bone mass and structure.

Citing Articles

"A Friend Among Strangers" or the Ambiguous Roles of Runx2.

Azarkina K, Gromova E, Malashicheva A Biomolecules. 2024; 14(11).

PMID: 39595568 PMC: 11591759. DOI: 10.3390/biom14111392.


A NOTCH2 pathogenic variant and HES1 regulate osteoclastogenesis in induced pluripotent stem cells.

Canalis E, Schilling L, Denker E, Stoddard C, Yu J Bone. 2024; 191:117334.

PMID: 39571704 PMC: 11624087. DOI: 10.1016/j.bone.2024.117334.


Indoxyl Sulfate Inhibits Osteogenesis in Bone Marrow Mesenchymal Stem Cells through the AhR/Hes1 Pathway.

Hsieh C, Chang L, Wang Y, Li W, Chang J, Chen C Int J Mol Sci. 2024; 25(16).

PMID: 39201457 PMC: 11354967. DOI: 10.3390/ijms25168770.


Application of dental pulp stem cells for bone regeneration.

Liu Y, Xiong W, Li J, Feng H, Jing S, Liu Y Front Med (Lausanne). 2024; 11:1339573.

PMID: 38487022 PMC: 10938947. DOI: 10.3389/fmed.2024.1339573.


ED-71 Prevents Glucocorticoid-Induced Osteoporosis by Regulating Osteoblast Differentiation via Notch and Wnt/β-Catenin Pathways.

Rong X, Kou Y, Zhang Y, Yang P, Tang R, Liu H Drug Des Devel Ther. 2022; 16:3929-3946.

PMID: 36411860 PMC: 9675334. DOI: 10.2147/DDDT.S377001.


References
1.
Kodama Y, Hijikata M, Kageyama R, Shimotohno K, Chiba T . The role of notch signaling in the development of intrahepatic bile ducts. Gastroenterology. 2004; 127(6):1775-86. DOI: 10.1053/j.gastro.2004.09.004. View

2.
Nazarenko I, Lowe B, Darfler M, Ikonomi P, Schuster D, Rashtchian A . Multiplex quantitative PCR using self-quenched primers labeled with a single fluorophore. Nucleic Acids Res. 2002; 30(9):e37. PMC: 113860. DOI: 10.1093/nar/30.9.e37. View

3.
Canalis E . Notch signaling in osteoblasts. Sci Signal. 2008; 1(17):pe17. DOI: 10.1126/stke.117pe17. View

4.
Fischer A, Gessler M . Delta-Notch--and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Nucleic Acids Res. 2007; 35(14):4583-96. PMC: 1950541. DOI: 10.1093/nar/gkm477. View

5.
Bianco P, Robey P . Marrow stromal stem cells. J Clin Invest. 2000; 105(12):1663-8. PMC: 378520. DOI: 10.1172/JCI10413. View